Regarding the role of MALAT1 in HCC, overexpression of MALAT1 in tumor tissues or sera may correlate with advanced tumor stages and reduced overall survival of HCC patients and indicate a higher risk of tumor recurrence following liver transplantation [15,16]. This evidence concerns the gene MALAT1 and hepatocellular carcinoma.